Rare diseases
Investigational molecules
Locations
63 B Avenue Ledru Rollin, 75012 Paris, France
eyeDNA Therapeutics focuses on retinitis pigmentosa, with particular interest in forms linked to PDE6B gene mutations and impaired PDE6β expression.
The sponsor’s clinical activity is centered on inherited vision loss and the molecular mechanisms underlying progressive retinal degeneration.
eyeDNA Therapeutics runs clinical trials in conditions such as Retinitis pigmentosa, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
